Edition:
India

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

21.69USD
26 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$21.69
Open
$21.75
Day's High
$21.76
Day's Low
$21.61
Volume
10,347
Avg. Vol
96,015
52-wk High
$22.58
52-wk Low
$18.54

Chart for

About

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease... (more)

Overall

Beta: 0.17
Market Cap(Mil.): $906.10
Shares Outstanding(Mil.): 44.07
Dividend: 0.06
Yield (%): 1.17

Financials

BRIEF-Luminex Corp Reports Q4 GAAP Loss Per Share $0.07

* ORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

13 Feb 2018

BRIEF-Luminex Corporation receives FDA clearance for Aries Group A Strep Assay

* Luminex Corporation receives FDA clearance for Aries Group A Strep Assay Source text for Eikon: Further company coverage:

01 Nov 2017

BRIEF-Luminex Corp reports Q3 earnings per share $0.40

* Luminex Corporation reports third quarter 2017 financial results

31 Oct 2017

Competitors

Earnings vs. Estimates